14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $58.40 $79.59 Thursday, 25th Apr 2024 EXAS stock ended at $58.79. This is 7.04% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.97% from a day low at $58.40 to a day high of $62.47.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Jun 08, 2021 $113.97 $116.14 $111.68 $114.03 1 564 715
Jun 07, 2021 $107.54 $112.79 $106.75 $112.06 1 266 389
Jun 04, 2021 $108.60 $109.81 $106.64 $106.83 862 072
Jun 03, 2021 $109.76 $110.85 $105.40 $107.91 1 061 713
Jun 02, 2021 $108.11 $109.91 $107.73 $109.12 1 124 845
Jun 01, 2021 $111.16 $112.41 $106.26 $108.37 1 529 153
May 28, 2021 $112.28 $115.05 $109.61 $110.53 1 265 969
May 27, 2021 $108.88 $111.59 $106.58 $111.19 1 693 443
May 26, 2021 $111.12 $111.67 $107.80 $109.04 1 278 846
May 25, 2021 $109.29 $112.21 $108.91 $109.88 1 503 511
May 24, 2021 $108.47 $110.69 $106.74 $109.48 1 579 734
May 21, 2021 $106.01 $108.61 $104.01 $106.29 1 652 566
May 20, 2021 $99.48 $107.02 $98.10 $105.74 3 342 872
May 19, 2021 $95.10 $97.84 $93.64 $96.86 1 639 948
May 18, 2021 $95.30 $101.77 $93.83 $96.58 2 253 266
May 17, 2021 $95.81 $96.31 $92.42 $94.67 1 089 662
May 14, 2021 $95.03 $99.29 $94.56 $96.74 1 404 992
May 13, 2021 $97.93 $99.24 $89.90 $93.66 2 167 363
May 12, 2021 $95.84 $98.10 $93.36 $96.11 2 990 603
May 11, 2021 $94.94 $101.41 $93.04 $98.00 2 629 654
May 10, 2021 $104.40 $104.40 $98.21 $98.84 2 636 506
May 07, 2021 $106.47 $110.73 $104.27 $104.50 1 680 952
May 06, 2021 $108.81 $110.00 $104.32 $108.01 2 233 315
May 05, 2021 $117.56 $119.55 $109.73 $110.65 2 436 511
May 04, 2021 $125.46 $125.46 $113.38 $116.02 3 114 624
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT